EBMT 2018: Investigating breakthrough therapies for treating AML in adults
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
Ibrutinib combination regimens for CLL from ASH 2017
The importance of MRD in multiple myeloma patients
The role of imaging techniques in defining response in multiple myeloma